« Factbook Table of Contents

6. Institute Public Advisory Committees

• National Heart, Lung, and Blood Advisory Council
• Program Advisory and Review Committee
  • Sickle Cell Disease Advisory Committee
  • Sleep Disorders Research Advisory Board
  • Heart, Lung, and Blood Initial Review Group
  • Heart, Lung, and Blood Program Project Review Committee
  • Clinical Trials Review Committee
  • National Heart, Lung, and Blood Institute Special Emphasis Panel
  • Board of Scientific Counselors

National Heart, Lung, and Blood Advisory Council

Structure

Chair: Elizabeth G. Nabel, M.D., Director, NHLBI

Executive Secretary: Stephen C. Mockrin, Ph.D., Director, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0260

The Secretary of HHS appoints 18 members: 12 members are leading representatives of the health and scientific disciplines (including public health and behavioral or social sciences), and 6 are from the general public and are leaders in the fields of public policy, law, health policy, economics, and management.

Members are appointed for overlapping terms of 4 years.

The Council includes the following ex officio members:

• Secretary, HHS
• Director, NIH
• Director, NHLBI
• Chief Medical Director, or Designee, Veterans Affairs
• Assistant Secretary of Defense for Health Affairs, or Designee.

Functions

The NHLBAC reviews applications for research grants, cooperative agreements, and training grants in heart, blood vessel, lung, and blood diseases; sleep disorders; and blood resources, and recommends scientific projects that merit support to the Director, NHLBI.

The Council advises the Secretary, HHS, the Assistant Secretary for Health, HHS, and the Directors, NIH and NHLBI, on matters relating to causes, prevention, and methods of diagnosis and treatment of diseases and resources within the purview of the Institute. As stated in its charter, the Council also “may review any grant, contract, or cooperative agreement proposed to be made or entered into by the Institute; may make recommendations to the Director of the Institute respecting research conducted at the Institute; may collect, by correspondence or by personal investigation, information as to studies that are being carried on in the United States or any other country with respect to the cause, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases, and to the use of blood and blood products and the management of blood resources and with the approval of the Director of the Institute, make available such information through appropriate publications for the benefit of public and private health entities and health professions personnel and scientists and for the information of the general public; and may appoint subcommittees and convene workshops and conferences.”

The Council may also make recommendations to the Director, NIH and other authorized officials regarding the acceptance of conditional gifts pursuant to section 2501 of the Public Health Service Act.

Meetings

The Chair convenes meetings not fewer than four times a year and approves the agenda.

Back to Top

National Heart, Lung, and Blood Advisory Council Membership*

Ex Officio Members

* Current as of October 2006. The current roster, containing full addresses for the NHLBI Advisory Council and Committees, can be obtained from the Internet at http://www.nhlbi.nih.gov/meetings/nhlbac/roster.htm.

Back to Top

Program Advisory and Review Committee

Sickle Cell Disease Advisory Committee

Chair: Floyd D. Armstrong, Ph.D., University of Miami School of Medicine

Executive Secretary: Robert B. Moore, Ph.D., Health Scientist Administrator, Division of Blood Diseases and Resources, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0050

The Sickle Cell Disease Advisory Committee advises the Secretary and the Assistant Secretary for Health, HHS and the Directors of the NIH, the NHLBI, and the DBDR on matters related to the Sickle Cell Disease Program and makes recommendations concerning planning, execution, and evaluation of all aspects of the program.

Membership*

Ex Officio Members

Back to Top

Sleep Disorders Research Advisory Board

Chair: Phyllis C. Zee, M.D., Ph.D., Northwestern University Medical School

Executive Secretary: Michael J. Twery, Ph.D., Acting Director, National Center on Sleep Disorders Re-search, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0202.

The Sleep Disorders Research Advisory Board advises the Directors of the NIH, the NHLBI, and the NCSDR on matters related to the scientific activities carried out by and through the Center and policies regarding such activities, including the identification of research priorities for coordination of sleep and sleep disorders research by the NIH and other federal, professional, and voluntary organizations.

Membership*

Ex Officio Members

Back to Top

Heart, Lung, and Blood Initial Review Group

Scientific Review Administrator: Jeffery H. Hurst, Ph.D., Health Science Administrator, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0303

The Heart, Lung, and Blood Initial Review Group provides initial technical merit review for the NHLBAC and the Director, NHLBI. This group consists of two subcommittees: the Heart, Lung, and Blood Program Project Review Committee and the Clinical Trials Review Committee.

Heart, Lung, and Blood Program Project Review Committee

Chair: Donna Przepiorka, M.D., Ph.D., University of Tennessee College of Medicine

Scientific Review Administrator: Jeffery H. Hurst, Ph.D., Health Scientist Administrator, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0303

The Heart, Lung, and Blood Program Project Review Committee provides initial technical merit review for the NHLBAC and the Director, NHLBI on program project applications proposing research in the areas of heart, lung, and blood diseases and resources.

Membership*

Back to Top

Clinical Trials Review Committee

Chair: Ileana L. Pina, M.D., Case Western Reserve University

Scientific Review Administrator: Patricia A. Haggerty, Ph.D., Health Science Administrator, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0288

The Clinical Trials Review Committee provides initial technical merit review for the NHLBAC and the Director of the NHLBI on clinical trial applications for the support of studies to evaluate preventive or therapeutic measures of blood, cardiovascular, or lung diseases.

Membership*

National Heart, Lung, and Blood Institute Special Emphasis Panel

The Institute has established the NHLBI Special Emphasis Panel (SEP) to perform initial peer review of applications and proposals that were previously handled by ad hoc committees. Concept review, previously handled by divisional program advisory committees, has also been incorporated into the SEP system. The SEP, which has neither a fixed membership nor a set meeting schedule, is constituted to provide required peer review expertise at precisely the time that it is needed.

Board of Scientific Counselors

Chair: Ivor J. Benjamin, M.D., University of Utah Health Sciences Center

Executive Secretary: Robert S. Balaban, Ph.D., Director, Laboratory Research Program, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–496–2116

The Board of Scientific Counselors advises the Director and the Deputy Director for Intramural Research, NIH, and the Directors of NHLBI and the Division of Intramural Research, NHLBI, on the intramural research programs of the NHLBI.

Membership*

* Current as of October 2006.

Back to Top

« Factbook Table of Contents